Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Nativi

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Journal of Cardiac Failure|January 1, 2016
Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom ScoreOmar F AbouEzzeddine, Yee Weng Wong, Robert J Mentz, et al.
Journal of Geriatric Cardiology : JGC|July 3, 2023
One-year survival in recipients older than 50 bridged to heart transplant with Impella 5.5 via axillary approachSmit Paghdar, Smruti Desai, Ji-Min Jang, et al.
JHLT Open|August 21, 2025
High profile transvalvular microaxial flow pump as a bridge to heart transplantation for amyloid cardiomyopathy: A case seriesPankaj Garg, Mohammad Alomari, Ishaq Wadiwala, et al.
Transplantation Proceedings|January 11, 2022
Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case ReportJose Nativi-Nicolau, Josef Stehlik, Aaron J Kelkhoff, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
Chronotropic incompetence and autonomic dysfunction as mechanisms of dyspnoea in patients with late stage cardiac amyloidosisJose Nativi-Nicolau, Josef Stehlik, Ragheed Al-Dulaimi, et al.
JACC. Heart Failure|December 14, 2020
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACTClaudio Rapezzi, Perry Elliott, Thibaud Damy, et al.
Circulation. Heart Failure|June 21, 2018
Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac ImagingDanny Varedi, Tibor Kovacsovics, Erinn Downs Kelly, et al.
Circulation. Heart Failure|February 26, 2020
Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter StudyJosef Stehlik, Carsten Schmalfuss, Biykem Bozkurt, et al.
JACC. Cardiooncology|November 3, 2021
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes SurveyJose Nativi-Nicolau, Alfonso Siu, Angela Dispenzieri, et al.
Journal of the American Heart Association|January 16, 2020
Provider Perspectives on the Feasibility and Utility of Routine Patient-Reported Outcomes Assessment in Heart Failure: A Qualitative AnalysisPeter Wohlfahrt, Susan L Zickmund, Stacey Slager, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Journal of Cardiac Failure|January 1, 2016
Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom ScoreOmar F AbouEzzeddine, Yee Weng Wong, Robert J Mentz, et al.
Journal of Geriatric Cardiology : JGC|July 3, 2023
One-year survival in recipients older than 50 bridged to heart transplant with Impella 5.5 via axillary approachSmit Paghdar, Smruti Desai, Ji-Min Jang, et al.
JHLT Open|August 21, 2025
High profile transvalvular microaxial flow pump as a bridge to heart transplantation for amyloid cardiomyopathy: A case seriesPankaj Garg, Mohammad Alomari, Ishaq Wadiwala, et al.
Transplantation Proceedings|January 11, 2022
Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case ReportJose Nativi-Nicolau, Josef Stehlik, Aaron J Kelkhoff, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
Chronotropic incompetence and autonomic dysfunction as mechanisms of dyspnoea in patients with late stage cardiac amyloidosisJose Nativi-Nicolau, Josef Stehlik, Ragheed Al-Dulaimi, et al.
JACC. Heart Failure|December 14, 2020
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACTClaudio Rapezzi, Perry Elliott, Thibaud Damy, et al.
Circulation. Heart Failure|June 21, 2018
Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac ImagingDanny Varedi, Tibor Kovacsovics, Erinn Downs Kelly, et al.
Circulation. Heart Failure|February 26, 2020
Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter StudyJosef Stehlik, Carsten Schmalfuss, Biykem Bozkurt, et al.
JACC. Cardiooncology|November 3, 2021
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes SurveyJose Nativi-Nicolau, Alfonso Siu, Angela Dispenzieri, et al.
Journal of the American Heart Association|January 16, 2020
Provider Perspectives on the Feasibility and Utility of Routine Patient-Reported Outcomes Assessment in Heart Failure: A Qualitative AnalysisPeter Wohlfahrt, Susan L Zickmund, Stacey Slager, et al.
Pageof 8